Medicines on a shelf of a prescription pharmacy is seen through its window in Tokyo, Japan, December 20, 2016. REUTERS/Kim Kyung-Hoon - RTX2VT9Y
JLL acquired 51 pct stake in Patheon in 2014
Most of firm’s equity came from Fund VI
Deal values Patheon at $3.8 bln
JLL Partners stands to make 4x to 5x its investment in Patheon NV, according to a source with knowledge of the deal. Thermo Fisher Scientific is expected to close its acquisition of the drug-manufacturing business in the next three to five ...